nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR2—Thalidomide—leprosy	0.453	0.617	CbGbCtD
Pazopanib—UGT1A1—Rifampicin—leprosy	0.0904	0.123	CbGbCtD
Pazopanib—SLCO1B1—Rifampicin—leprosy	0.0626	0.0853	CbGbCtD
Pazopanib—CYP2C8—Rifampicin—leprosy	0.0265	0.0361	CbGbCtD
Pazopanib—CYP2C8—Dapsone—leprosy	0.0219	0.0298	CbGbCtD
Pazopanib—CYP1A2—Thalidomide—leprosy	0.0212	0.0289	CbGbCtD
Pazopanib—CYP1A2—Rifampicin—leprosy	0.0205	0.028	CbGbCtD
Pazopanib—ABCB1—Rifampicin—leprosy	0.0179	0.0244	CbGbCtD
Pazopanib—CYP3A4—Rifampicin—leprosy	0.0107	0.0146	CbGbCtD
Pazopanib—CYP3A4—Dapsone—leprosy	0.00887	0.0121	CbGbCtD
Pazopanib—Phosphorus low—Thalidomide—leprosy	0.00764	0.067	CcSEcCtD
Pazopanib—Blood phosphorus decreased—Thalidomide—leprosy	0.00607	0.0532	CcSEcCtD
Pazopanib—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00536	0.0471	CcSEcCtD
Pazopanib—FGFR3—appendage—leprosy	0.00473	0.045	CbGeAlD
Pazopanib—BMPR1B—peripheral nervous system—leprosy	0.00426	0.0405	CbGeAlD
Pazopanib—FGFR3—skin epidermis—leprosy	0.00393	0.0374	CbGeAlD
Pazopanib—Peritonitis—Thalidomide—leprosy	0.00348	0.0306	CcSEcCtD
Pazopanib—Gastrointestinal perforation—Thalidomide—leprosy	0.00337	0.0296	CcSEcCtD
Pazopanib—FGF1—appendage—leprosy	0.00328	0.0312	CbGeAlD
Pazopanib—Thromboembolic event—Thalidomide—leprosy	0.00327	0.0287	CcSEcCtD
Pazopanib—Peripheral sensory neuropathy—Thalidomide—leprosy	0.00308	0.027	CcSEcCtD
Pazopanib—PLK4—Menadione—Thalidomide—leprosy	0.003	1	CbGdCrCtD
Pazopanib—Lipase increased—Thalidomide—leprosy	0.003	0.0263	CcSEcCtD
Pazopanib—KDR—hindlimb—leprosy	0.00283	0.0269	CbGeAlD
Pazopanib—FGF1—skin epidermis—leprosy	0.00273	0.0259	CbGeAlD
Pazopanib—FGFR2—skin epidermis—leprosy	0.00257	0.0245	CbGeAlD
Pazopanib—KDR—appendage—leprosy	0.00242	0.0231	CbGeAlD
Pazopanib—FGF1—nerve—leprosy	0.00232	0.0221	CbGeAlD
Pazopanib—Intestinal perforation—Thalidomide—leprosy	0.00223	0.0195	CcSEcCtD
Pazopanib—FLT4—blood vessel—leprosy	0.00205	0.0195	CbGeAlD
Pazopanib—Proteinuria—Dapsone—leprosy	0.00196	0.0172	CcSEcCtD
Pazopanib—Protein urine present—Dapsone—leprosy	0.00193	0.0169	CcSEcCtD
Pazopanib—FGF1—blood vessel—leprosy	0.00182	0.0174	CbGeAlD
Pazopanib—Sinus bradycardia—Thalidomide—leprosy	0.0018	0.0157	CcSEcCtD
Pazopanib—KIT—skin epidermis—leprosy	0.00179	0.017	CbGeAlD
Pazopanib—TAOK1—eye—leprosy	0.00178	0.0169	CbGeAlD
Pazopanib—White blood cell count decreased—Thalidomide—leprosy	0.00177	0.0155	CcSEcCtD
Pazopanib—Transient ischaemic attack—Thalidomide—leprosy	0.00174	0.0153	CcSEcCtD
Pazopanib—Lymphopenia—Thalidomide—leprosy	0.00172	0.0151	CcSEcCtD
Pazopanib—SH2B3—eye—leprosy	0.00167	0.0159	CbGeAlD
Pazopanib—Skin exfoliation—Dapsone—leprosy	0.00164	0.0144	CcSEcCtD
Pazopanib—FLT1—blood vessel—leprosy	0.0016	0.0152	CbGeAlD
Pazopanib—Platelet count decreased—Thalidomide—leprosy	0.00148	0.013	CcSEcCtD
Pazopanib—Deep vein thrombosis—Thalidomide—leprosy	0.00145	0.0127	CcSEcCtD
Pazopanib—Hypomagnesaemia—Thalidomide—leprosy	0.00139	0.0122	CcSEcCtD
Pazopanib—Embolism—Thalidomide—leprosy	0.00137	0.012	CcSEcCtD
Pazopanib—Hypothyroidism—Thalidomide—leprosy	0.00137	0.012	CcSEcCtD
Pazopanib—Nail disorder—Thalidomide—leprosy	0.00136	0.0119	CcSEcCtD
Pazopanib—KDR—blood vessel—leprosy	0.00135	0.0128	CbGeAlD
Pazopanib—MAP3K9—testis—leprosy	0.0013	0.0124	CbGeAlD
Pazopanib—MAP3K9—nervous system—leprosy	0.00127	0.0121	CbGeAlD
Pazopanib—Thrombosis—Thalidomide—leprosy	0.00124	0.0109	CcSEcCtD
Pazopanib—Metrorrhagia—Thalidomide—leprosy	0.00123	0.0108	CcSEcCtD
Pazopanib—FGFR3—skin of body—leprosy	0.00122	0.0116	CbGeAlD
Pazopanib—KIT—blood vessel—leprosy	0.0012	0.0114	CbGeAlD
Pazopanib—PDGFRB—blood vessel—leprosy	0.00117	0.0111	CbGeAlD
Pazopanib—Skin ulcer—Thalidomide—leprosy	0.00113	0.00992	CcSEcCtD
Pazopanib—Nasopharyngitis—Dapsone—leprosy	0.00112	0.00979	CcSEcCtD
Pazopanib—SH2B3—tendon—leprosy	0.00111	0.0105	CbGeAlD
Pazopanib—Myocardial ischaemia—Thalidomide—leprosy	0.0011	0.00961	CcSEcCtD
Pazopanib—FLT4—eye—leprosy	0.00109	0.0104	CbGeAlD
Pazopanib—AURKC—tendon—leprosy	0.00109	0.0104	CbGeAlD
Pazopanib—ITK—testis—leprosy	0.00107	0.0102	CbGeAlD
Pazopanib—Endocrine disorder—Thalidomide—leprosy	0.00106	0.00932	CcSEcCtD
Pazopanib—Pancreatitis—Dapsone—leprosy	0.00106	0.00928	CcSEcCtD
Pazopanib—Proteinuria—Thalidomide—leprosy	0.001	0.00879	CcSEcCtD
Pazopanib—Protein urine present—Thalidomide—leprosy	0.000988	0.00867	CcSEcCtD
Pazopanib—Photosensitivity reaction—Dapsone—leprosy	0.000985	0.00864	CcSEcCtD
Pazopanib—Skin discolouration—Thalidomide—leprosy	0.000975	0.00855	CcSEcCtD
Pazopanib—TAOK1—testis—leprosy	0.000975	0.00928	CbGeAlD
Pazopanib—FGF1—eye—leprosy	0.000971	0.00924	CbGeAlD
Pazopanib—Hyperbilirubinaemia—Thalidomide—leprosy	0.000968	0.00849	CcSEcCtD
Pazopanib—TAOK1—nervous system—leprosy	0.000957	0.0091	CbGeAlD
Pazopanib—STK16—tendon—leprosy	0.000942	0.00897	CbGeAlD
Pazopanib—RIOK2—tendon—leprosy	0.000928	0.00883	CbGeAlD
Pazopanib—Creatinine increased—Thalidomide—leprosy	0.000925	0.00811	CcSEcCtD
Pazopanib—SH2B3—testis—leprosy	0.000918	0.00873	CbGeAlD
Pazopanib—FGFR2—eye—leprosy	0.000917	0.00873	CbGeAlD
Pazopanib—AURKC—testis—leprosy	0.000903	0.0086	CbGeAlD
Pazopanib—SH2B3—nervous system—leprosy	0.000901	0.00857	CbGeAlD
Pazopanib—AURKC—nervous system—leprosy	0.000886	0.00844	CbGeAlD
Pazopanib—Phosphatase alkaline increased—Thalidomide—leprosy	0.00088	0.00772	CcSEcCtD
Pazopanib—Pulmonary embolism—Thalidomide—leprosy	0.00088	0.00772	CcSEcCtD
Pazopanib—FLT1—eye—leprosy	0.00085	0.00809	CbGeAlD
Pazopanib—FGF1—skin of body—leprosy	0.000845	0.00804	CbGeAlD
Pazopanib—Skin exfoliation—Thalidomide—leprosy	0.00084	0.00737	CcSEcCtD
Pazopanib—STK36—tendon—leprosy	0.000833	0.00793	CbGeAlD
Pazopanib—Blood urea increased—Thalidomide—leprosy	0.000831	0.00729	CcSEcCtD
Pazopanib—PLK4—testis—leprosy	0.000826	0.00786	CbGeAlD
Pazopanib—PI4KB—tendon—leprosy	0.00082	0.00781	CbGeAlD
Pazopanib—TAOK3—eye—leprosy	0.000801	0.00763	CbGeAlD
Pazopanib—FGFR2—skin of body—leprosy	0.000798	0.00759	CbGeAlD
Pazopanib—STK16—testis—leprosy	0.00078	0.00743	CbGeAlD
Pazopanib—RIOK2—testis—leprosy	0.000768	0.00731	CbGeAlD
Pazopanib—FGFR3—testis—leprosy	0.000768	0.00731	CbGeAlD
Pazopanib—STK16—nervous system—leprosy	0.000766	0.00729	CbGeAlD
Pazopanib—BMPR1B—testis—leprosy	0.00076	0.00724	CbGeAlD
Pazopanib—MAP3K19—testis—leprosy	0.00076	0.00724	CbGeAlD
Pazopanib—LYN—nervous system—leprosy	0.000758	0.00721	CbGeAlD
Pazopanib—RIOK2—nervous system—leprosy	0.000754	0.00717	CbGeAlD
Pazopanib—FGFR3—nervous system—leprosy	0.000754	0.00717	CbGeAlD
Pazopanib—Erythema—Dapsone—leprosy	0.000752	0.0066	CcSEcCtD
Pazopanib—MAP3K19—nervous system—leprosy	0.000746	0.0071	CbGeAlD
Pazopanib—BMPR1B—nervous system—leprosy	0.000746	0.0071	CbGeAlD
Pazopanib—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000735	0.00645	CcSEcCtD
Pazopanib—EPHB6—skin of body—leprosy	0.000731	0.00696	CbGeAlD
Pazopanib—PIP4K2C—tendon—leprosy	0.00072	0.00685	CbGeAlD
Pazopanib—KDR—eye—leprosy	0.000718	0.00684	CbGeAlD
Pazopanib—FGFR1—tendon—leprosy	0.000714	0.0068	CbGeAlD
Pazopanib—Vision blurred—Dapsone—leprosy	0.000709	0.00622	CcSEcCtD
Pazopanib—Cardiac failure congestive—Thalidomide—leprosy	0.000705	0.00618	CcSEcCtD
Pazopanib—CSF1R—eye—leprosy	0.000701	0.00667	CbGeAlD
Pazopanib—STK36—testis—leprosy	0.00069	0.00657	CbGeAlD
Pazopanib—PI4KB—testis—leprosy	0.000679	0.00647	CbGeAlD
Pazopanib—STK36—nervous system—leprosy	0.000677	0.00644	CbGeAlD
Pazopanib—LIMK2—testis—leprosy	0.000667	0.00635	CbGeAlD
Pazopanib—PI4KB—nervous system—leprosy	0.000667	0.00635	CbGeAlD
Pazopanib—Cough—Dapsone—leprosy	0.000656	0.00576	CcSEcCtD
Pazopanib—Cardiac failure—Thalidomide—leprosy	0.000655	0.00574	CcSEcCtD
Pazopanib—LIMK2—nervous system—leprosy	0.000655	0.00623	CbGeAlD
Pazopanib—Cerebrovascular accident—Thalidomide—leprosy	0.000652	0.00572	CcSEcCtD
Pazopanib—Lethargy—Thalidomide—leprosy	0.000652	0.00572	CcSEcCtD
Pazopanib—Hyponatraemia—Thalidomide—leprosy	0.000642	0.00563	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000639	0.00561	CcSEcCtD
Pazopanib—PDGFRB—eye—leprosy	0.000622	0.00592	CbGeAlD
Pazopanib—Face oedema—Thalidomide—leprosy	0.000617	0.00541	CcSEcCtD
Pazopanib—CSF1R—skin of body—leprosy	0.00061	0.00581	CbGeAlD
Pazopanib—FLT4—testis—leprosy	0.000599	0.0057	CbGeAlD
Pazopanib—Blood creatinine increased—Thalidomide—leprosy	0.000599	0.00525	CcSEcCtD
Pazopanib—PIP4K2C—testis—leprosy	0.000596	0.00567	CbGeAlD
Pazopanib—Dehydration—Thalidomide—leprosy	0.000594	0.00521	CcSEcCtD
Pazopanib—FGFR1—testis—leprosy	0.000591	0.00563	CbGeAlD
Pazopanib—Liver function test abnormal—Thalidomide—leprosy	0.00059	0.00518	CcSEcCtD
Pazopanib—Dry skin—Thalidomide—leprosy	0.000586	0.00514	CcSEcCtD
Pazopanib—PIP4K2C—nervous system—leprosy	0.000585	0.00557	CbGeAlD
Pazopanib—Breast disorder—Thalidomide—leprosy	0.000577	0.00507	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000575	0.00505	CcSEcCtD
Pazopanib—MAP3K2—testis—leprosy	0.000565	0.00538	CbGeAlD
Pazopanib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000564	0.00494	CcSEcCtD
Pazopanib—FLT1—tendon—leprosy	0.000563	0.00536	CbGeAlD
Pazopanib—EPHB6—tendon—leprosy	0.000556	0.0053	CbGeAlD
Pazopanib—Abdominal distension—Thalidomide—leprosy	0.000556	0.00488	CcSEcCtD
Pazopanib—Insomnia—Dapsone—leprosy	0.000555	0.00487	CcSEcCtD
Pazopanib—MAP3K2—nervous system—leprosy	0.000555	0.00528	CbGeAlD
Pazopanib—KIT—skin of body—leprosy	0.000554	0.00527	CbGeAlD
Pazopanib—Pancreatitis—Thalidomide—leprosy	0.000542	0.00475	CcSEcCtD
Pazopanib—PDGFRB—skin of body—leprosy	0.000541	0.00515	CbGeAlD
Pazopanib—STK10—tendon—leprosy	0.000533	0.00507	CbGeAlD
Pazopanib—FGF1—testis—leprosy	0.000532	0.00507	CbGeAlD
Pazopanib—TAOK3—tendon—leprosy	0.000531	0.00505	CbGeAlD
Pazopanib—LCK—testis—leprosy	0.000529	0.00504	CbGeAlD
Pazopanib—PDGFRA—tendon—leprosy	0.000527	0.00502	CbGeAlD
Pazopanib—FGF1—nervous system—leprosy	0.000522	0.00497	CbGeAlD
Pazopanib—Neutropenia—Thalidomide—leprosy	0.000516	0.00453	CcSEcCtD
Pazopanib—Photosensitivity reaction—Thalidomide—leprosy	0.000504	0.00442	CcSEcCtD
Pazopanib—FGFR2—testis—leprosy	0.000503	0.00479	CbGeAlD
Pazopanib—Gastrointestinal pain—Dapsone—leprosy	0.000502	0.0044	CcSEcCtD
Pazopanib—Weight decreased—Thalidomide—leprosy	0.0005	0.00438	CcSEcCtD
Pazopanib—FGFR2—nervous system—leprosy	0.000493	0.0047	CbGeAlD
Pazopanib—Infestation—Thalidomide—leprosy	0.000492	0.00432	CcSEcCtD
Pazopanib—Infestation NOS—Thalidomide—leprosy	0.000492	0.00432	CcSEcCtD
Pazopanib—Acute coronary syndrome—Thalidomide—leprosy	0.000485	0.00426	CcSEcCtD
Pazopanib—Abdominal pain—Dapsone—leprosy	0.000485	0.00426	CcSEcCtD
Pazopanib—Myocardial infarction—Thalidomide—leprosy	0.000483	0.00424	CcSEcCtD
Pazopanib—Stomatitis—Thalidomide—leprosy	0.00048	0.00421	CcSEcCtD
Pazopanib—KDR—tendon—leprosy	0.000476	0.00453	CbGeAlD
Pazopanib—MAP2K5—tendon—leprosy	0.000476	0.00453	CbGeAlD
Pazopanib—Haematuria—Thalidomide—leprosy	0.00047	0.00412	CcSEcCtD
Pazopanib—FLT1—testis—leprosy	0.000466	0.00444	CbGeAlD
Pazopanib—Epistaxis—Thalidomide—leprosy	0.000465	0.00408	CcSEcCtD
Pazopanib—CSF1R—tendon—leprosy	0.000464	0.00442	CbGeAlD
Pazopanib—EPHB6—testis—leprosy	0.000461	0.00438	CbGeAlD
Pazopanib—FLT1—nervous system—leprosy	0.000457	0.00435	CbGeAlD
Pazopanib—EPHB6—nervous system—leprosy	0.000452	0.0043	CbGeAlD
Pazopanib—Bradycardia—Thalidomide—leprosy	0.00045	0.00395	CcSEcCtD
Pazopanib—STK10—testis—leprosy	0.000441	0.0042	CbGeAlD
Pazopanib—Hypoaesthesia—Thalidomide—leprosy	0.00044	0.00386	CcSEcCtD
Pazopanib—TAOK3—testis—leprosy	0.000439	0.00418	CbGeAlD
Pazopanib—PDGFRA—testis—leprosy	0.000437	0.00416	CbGeAlD
Pazopanib—Urinary tract disorder—Thalidomide—leprosy	0.000437	0.00383	CcSEcCtD
Pazopanib—Oedema peripheral—Thalidomide—leprosy	0.000436	0.00382	CcSEcCtD
Pazopanib—Urethral disorder—Thalidomide—leprosy	0.000433	0.0038	CcSEcCtD
Pazopanib—STK10—nervous system—leprosy	0.000433	0.00412	CbGeAlD
Pazopanib—TAOK3—nervous system—leprosy	0.000431	0.00411	CbGeAlD
Pazopanib—PDGFRA—nervous system—leprosy	0.000429	0.00408	CbGeAlD
Pazopanib—Eye disorder—Thalidomide—leprosy	0.000413	0.00362	CcSEcCtD
Pazopanib—PDGFRB—tendon—leprosy	0.000412	0.00392	CbGeAlD
Pazopanib—Cardiac disorder—Thalidomide—leprosy	0.00041	0.0036	CcSEcCtD
Pazopanib—Angiopathy—Thalidomide—leprosy	0.000401	0.00352	CcSEcCtD
Pazopanib—Mediastinal disorder—Thalidomide—leprosy	0.000398	0.0035	CcSEcCtD
Pazopanib—Chills—Thalidomide—leprosy	0.000397	0.00348	CcSEcCtD
Pazopanib—KDR—testis—leprosy	0.000394	0.00375	CbGeAlD
Pazopanib—MAP2K5—testis—leprosy	0.000394	0.00375	CbGeAlD
Pazopanib—Alopecia—Thalidomide—leprosy	0.000391	0.00343	CcSEcCtD
Pazopanib—Vomiting—Dapsone—leprosy	0.00039	0.00342	CcSEcCtD
Pazopanib—Mental disorder—Thalidomide—leprosy	0.000387	0.0034	CcSEcCtD
Pazopanib—KDR—nervous system—leprosy	0.000387	0.00368	CbGeAlD
Pazopanib—MAP2K5—nervous system—leprosy	0.000387	0.00368	CbGeAlD
Pazopanib—Malnutrition—Thalidomide—leprosy	0.000385	0.00338	CcSEcCtD
Pazopanib—CSF1R—testis—leprosy	0.000384	0.00366	CbGeAlD
Pazopanib—Headache—Dapsone—leprosy	0.000384	0.00337	CcSEcCtD
Pazopanib—Flatulence—Thalidomide—leprosy	0.000379	0.00333	CcSEcCtD
Pazopanib—CSF1R—nervous system—leprosy	0.000377	0.00359	CbGeAlD
Pazopanib—Dysgeusia—Thalidomide—leprosy	0.000377	0.00331	CcSEcCtD
Pazopanib—Muscle spasms—Thalidomide—leprosy	0.00037	0.00325	CcSEcCtD
Pazopanib—Nausea—Dapsone—leprosy	0.000364	0.0032	CcSEcCtD
Pazopanib—Vision blurred—Thalidomide—leprosy	0.000363	0.00318	CcSEcCtD
Pazopanib—Anaemia—Thalidomide—leprosy	0.000356	0.00312	CcSEcCtD
Pazopanib—KIT—testis—leprosy	0.000349	0.00332	CbGeAlD
Pazopanib—Syncope—Thalidomide—leprosy	0.000345	0.00303	CcSEcCtD
Pazopanib—Leukopenia—Thalidomide—leprosy	0.000344	0.00302	CcSEcCtD
Pazopanib—KIT—nervous system—leprosy	0.000343	0.00326	CbGeAlD
Pazopanib—PDGFRB—testis—leprosy	0.000341	0.00325	CbGeAlD
Pazopanib—Loss of consciousness—Thalidomide—leprosy	0.000338	0.00297	CcSEcCtD
Pazopanib—Cough—Thalidomide—leprosy	0.000336	0.00295	CcSEcCtD
Pazopanib—PDGFRB—nervous system—leprosy	0.000335	0.00319	CbGeAlD
Pazopanib—Hypertension—Thalidomide—leprosy	0.000332	0.00292	CcSEcCtD
Pazopanib—Chest pain—Thalidomide—leprosy	0.000328	0.00287	CcSEcCtD
Pazopanib—Myalgia—Thalidomide—leprosy	0.000328	0.00287	CcSEcCtD
Pazopanib—Arthralgia—Thalidomide—leprosy	0.000328	0.00287	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000325	0.00285	CcSEcCtD
Pazopanib—ABCB1—blood vessel—leprosy	0.000324	0.00308	CbGeAlD
Pazopanib—Dry mouth—Thalidomide—leprosy	0.00032	0.00281	CcSEcCtD
Pazopanib—Oedema—Thalidomide—leprosy	0.000314	0.00276	CcSEcCtD
Pazopanib—Infection—Thalidomide—leprosy	0.000312	0.00274	CcSEcCtD
Pazopanib—Shock—Thalidomide—leprosy	0.000309	0.00271	CcSEcCtD
Pazopanib—Nervous system disorder—Thalidomide—leprosy	0.000308	0.0027	CcSEcCtD
Pazopanib—Thrombocytopenia—Thalidomide—leprosy	0.000308	0.0027	CcSEcCtD
Pazopanib—Skin disorder—Thalidomide—leprosy	0.000305	0.00268	CcSEcCtD
Pazopanib—Hyperhidrosis—Thalidomide—leprosy	0.000304	0.00266	CcSEcCtD
Pazopanib—Anorexia—Thalidomide—leprosy	0.000299	0.00263	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000286	0.00251	CcSEcCtD
Pazopanib—Insomnia—Thalidomide—leprosy	0.000284	0.00249	CcSEcCtD
Pazopanib—Paraesthesia—Thalidomide—leprosy	0.000282	0.00247	CcSEcCtD
Pazopanib—Dyspnoea—Thalidomide—leprosy	0.00028	0.00246	CcSEcCtD
Pazopanib—Somnolence—Thalidomide—leprosy	0.000279	0.00245	CcSEcCtD
Pazopanib—Dyspepsia—Thalidomide—leprosy	0.000276	0.00243	CcSEcCtD
Pazopanib—Decreased appetite—Thalidomide—leprosy	0.000273	0.0024	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Thalidomide—leprosy	0.000271	0.00238	CcSEcCtD
Pazopanib—Fatigue—Thalidomide—leprosy	0.000271	0.00238	CcSEcCtD
Pazopanib—Pain—Thalidomide—leprosy	0.000269	0.00236	CcSEcCtD
Pazopanib—Gastrointestinal pain—Thalidomide—leprosy	0.000257	0.00225	CcSEcCtD
Pazopanib—Abdominal pain—Thalidomide—leprosy	0.000248	0.00218	CcSEcCtD
Pazopanib—Asthenia—Thalidomide—leprosy	0.000225	0.00198	CcSEcCtD
Pazopanib—Pruritus—Thalidomide—leprosy	0.000222	0.00195	CcSEcCtD
Pazopanib—Diarrhoea—Thalidomide—leprosy	0.000215	0.00189	CcSEcCtD
Pazopanib—Dizziness—Thalidomide—leprosy	0.000208	0.00182	CcSEcCtD
Pazopanib—Vomiting—Thalidomide—leprosy	0.0002	0.00175	CcSEcCtD
Pazopanib—Rash—Thalidomide—leprosy	0.000198	0.00174	CcSEcCtD
Pazopanib—Dermatitis—Thalidomide—leprosy	0.000198	0.00174	CcSEcCtD
Pazopanib—CYP2C8—testis—leprosy	0.000197	0.00188	CbGeAlD
Pazopanib—Headache—Thalidomide—leprosy	0.000197	0.00173	CcSEcCtD
Pazopanib—ABCG2—testis—leprosy	0.000192	0.00182	CbGeAlD
Pazopanib—Nausea—Thalidomide—leprosy	0.000187	0.00164	CcSEcCtD
Pazopanib—CYP2D6—testis—leprosy	0.000131	0.00125	CbGeAlD
Pazopanib—CYP3A4—nervous system—leprosy	0.000131	0.00125	CbGeAlD
Pazopanib—CYP2D6—nervous system—leprosy	0.000129	0.00123	CbGeAlD
Pazopanib—ABCB1—testis—leprosy	9.45e-05	0.000899	CbGeAlD
Pazopanib—ABCB1—nervous system—leprosy	9.27e-05	0.000883	CbGeAlD
Pazopanib—FLT4—Signaling Pathways—RIPK2—leprosy	6.15e-05	0.00138	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—RIPK2—leprosy	6.15e-05	0.00138	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	6.14e-05	0.00138	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—RIPK2—leprosy	6.04e-05	0.00136	CbGpPWpGaD
Pazopanib—ITK—Immune System—HLA-DRB1—leprosy	5.97e-05	0.00134	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—RIPK2—leprosy	5.97e-05	0.00134	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—TLR2—leprosy	5.97e-05	0.00134	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—RIPK2—leprosy	5.95e-05	0.00134	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—TLR2—leprosy	5.95e-05	0.00134	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—leprosy	5.94e-05	0.00134	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—NOD2—leprosy	5.81e-05	0.00131	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CYLD—leprosy	5.79e-05	0.0013	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	5.78e-05	0.0013	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—RIPK2—leprosy	5.73e-05	0.00129	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—RIPK2—leprosy	5.72e-05	0.00129	CbGpPWpGaD
Pazopanib—FGF1—Disease—SLC11A1—leprosy	5.71e-05	0.00128	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—NOD2—leprosy	5.7e-05	0.00128	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD40LG—leprosy	5.7e-05	0.00128	CbGpPWpGaD
Pazopanib—KIT—Immune System—CYLD—leprosy	5.69e-05	0.00128	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—PARK2—leprosy	5.67e-05	0.00127	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD8A—leprosy	5.63e-05	0.00127	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—HLA-DRB1—leprosy	5.52e-05	0.00124	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	5.5e-05	0.00124	CbGpPWpGaD
Pazopanib—FGF1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.47e-05	0.00123	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	5.45e-05	0.00123	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—RIPK2—leprosy	5.42e-05	0.00122	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—TLR2—leprosy	5.42e-05	0.00122	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—NOD2—leprosy	5.41e-05	0.00122	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—NOD2—leprosy	5.4e-05	0.00121	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CYLD—leprosy	5.4e-05	0.00121	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CYLD—leprosy	5.38e-05	0.00121	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—RIPK2—leprosy	5.36e-05	0.00121	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—TLR2—leprosy	5.36e-05	0.00121	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—RIPK2—leprosy	5.25e-05	0.00118	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—TLR2—leprosy	5.25e-05	0.00118	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—RIPK2—leprosy	5.15e-05	0.00116	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—PARK2—leprosy	5.12e-05	0.00115	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—RIPK2—leprosy	5.04e-05	0.00113	CbGpPWpGaD
Pazopanib—KIT—Immune System—PARK2—leprosy	5.03e-05	0.00113	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—IFNG—leprosy	4.99e-05	0.00112	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—NOD2—leprosy	4.92e-05	0.00111	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—NOD2—leprosy	4.86e-05	0.00109	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CYLD—leprosy	4.85e-05	0.00109	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—PARK2—leprosy	4.77e-05	0.00107	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—NOD2—leprosy	4.76e-05	0.00107	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—PARK2—leprosy	4.76e-05	0.00107	CbGpPWpGaD
Pazopanib—LYN—Immune System—CYLD—leprosy	4.75e-05	0.00107	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	4.74e-05	0.00106	CbGpPWpGaD
Pazopanib—FGFR2—Disease—SLC11A1—leprosy	4.72e-05	0.00106	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD40LG—leprosy	4.71e-05	0.00106	CbGpPWpGaD
Pazopanib—FGFR1—MAPK Signaling Pathway—TNF—leprosy	4.67e-05	0.00105	CbGpPWpGaD
Pazopanib—LIMK2—Developmental Biology—TNF—leprosy	4.66e-05	0.00105	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD8A—leprosy	4.66e-05	0.00105	CbGpPWpGaD
Pazopanib—KIT—Disease—SLC11A1—leprosy	4.64e-05	0.00104	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD40LG—leprosy	4.63e-05	0.00104	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—RIPK2—leprosy	4.59e-05	0.00103	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—HLA-DRB1—leprosy	4.59e-05	0.00103	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD8A—leprosy	4.58e-05	0.00103	CbGpPWpGaD
Pazopanib—LYN—Platelet activation, signaling and aggregation—IL2—leprosy	4.53e-05	0.00102	CbGpPWpGaD
Pazopanib—FGF1—Immune System—RIPK2—leprosy	4.51e-05	0.00101	CbGpPWpGaD
Pazopanib—FGF1—Immune System—TLR2—leprosy	4.51e-05	0.00101	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—IL2—leprosy	4.43e-05	0.000996	CbGpPWpGaD
Pazopanib—FGFR1—Disease—SLC11A1—leprosy	4.4e-05	0.00099	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD40LG—leprosy	4.39e-05	0.000988	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—SLC11A1—leprosy	4.39e-05	0.000987	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—TNF—leprosy	4.39e-05	0.000986	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD40LG—leprosy	4.38e-05	0.000985	CbGpPWpGaD
Pazopanib—ITK—Immune System—IFNG—leprosy	4.36e-05	0.00098	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD8A—leprosy	4.34e-05	0.000977	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD8A—leprosy	4.33e-05	0.000974	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—RIPK2—leprosy	4.3e-05	0.000968	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—TLR2—leprosy	4.3e-05	0.000968	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PARK2—leprosy	4.29e-05	0.000963	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—IFNG—leprosy	4.22e-05	0.000949	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.22e-05	0.000948	CbGpPWpGaD
Pazopanib—ITK—Immune System—CD4—leprosy	4.21e-05	0.000947	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.21e-05	0.000945	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—TNF—leprosy	4.2e-05	0.000944	CbGpPWpGaD
Pazopanib—LYN—Immune System—PARK2—leprosy	4.2e-05	0.000943	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD40LG—leprosy	4.16e-05	0.000934	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—RIPK2—leprosy	4.13e-05	0.000929	CbGpPWpGaD
Pazopanib—LCK—HIV Infection—CD4—leprosy	4.11e-05	0.000924	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD8A—leprosy	4.11e-05	0.000924	CbGpPWpGaD
Pazopanib—FGF1—Immune System—NOD2—leprosy	4.09e-05	0.000919	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—CD4—leprosy	4.05e-05	0.000911	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—SDHD—leprosy	4.04e-05	0.000908	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	3.97e-05	0.000893	CbGpPWpGaD
Pazopanib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	3.97e-05	0.000893	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—SLC11A1—leprosy	3.96e-05	0.000889	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD40LG—leprosy	3.95e-05	0.000887	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD8A—leprosy	3.9e-05	0.000878	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—NOD2—leprosy	3.9e-05	0.000877	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—CD4—leprosy	3.89e-05	0.000875	CbGpPWpGaD
Pazopanib—LCK—Immune System—CYLD—leprosy	3.89e-05	0.000875	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—IL2—leprosy	3.89e-05	0.000874	CbGpPWpGaD
Pazopanib—ITK—Immune System—IL2—leprosy	3.87e-05	0.000871	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD40LG—leprosy	3.87e-05	0.000869	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD8A—leprosy	3.82e-05	0.000859	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—HLA-DRB1—leprosy	3.8e-05	0.000853	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—IL2—leprosy	3.75e-05	0.000843	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—RIPK2—leprosy	3.73e-05	0.000839	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—TLR2—leprosy	3.73e-05	0.000839	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—HLA-DRB1—leprosy	3.73e-05	0.000838	CbGpPWpGaD
Pazopanib—LCK—Platelet activation, signaling and aggregation—IL2—leprosy	3.71e-05	0.000835	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—SDHD—leprosy	3.7e-05	0.000832	CbGpPWpGaD
Pazopanib—KIT—Immune System—RIPK2—leprosy	3.66e-05	0.000824	CbGpPWpGaD
Pazopanib—KIT—Immune System—TLR2—leprosy	3.66e-05	0.000824	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HLA-DRB1—leprosy	3.54e-05	0.000795	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HLA-DRB1—leprosy	3.53e-05	0.000793	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—RIPK2—leprosy	3.51e-05	0.000788	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—RIPK2—leprosy	3.48e-05	0.000782	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—TLR2—leprosy	3.48e-05	0.000782	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—RIPK2—leprosy	3.47e-05	0.00078	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—TLR2—leprosy	3.47e-05	0.00078	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IFNG—leprosy	3.46e-05	0.000778	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD40LG—leprosy	3.45e-05	0.000777	CbGpPWpGaD
Pazopanib—LCK—Immune System—PARK2—leprosy	3.44e-05	0.000773	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—SDHD—leprosy	3.43e-05	0.00077	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD8A—leprosy	3.42e-05	0.000768	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NOD2—leprosy	3.38e-05	0.00076	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—CD4—leprosy	3.37e-05	0.000757	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HLA-DRB1—leprosy	3.35e-05	0.000752	CbGpPWpGaD
Pazopanib—KIT—Immune System—NOD2—leprosy	3.32e-05	0.000747	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD4—leprosy	3.23e-05	0.000727	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—TNF—leprosy	3.23e-05	0.000725	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	3.18e-05	0.000715	CbGpPWpGaD
Pazopanib—LCK—Disease—SLC11A1—leprosy	3.18e-05	0.000714	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD40LG—leprosy	3.17e-05	0.000712	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NOD2—leprosy	3.15e-05	0.000709	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NOD2—leprosy	3.14e-05	0.000707	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—RIPK2—leprosy	3.13e-05	0.000705	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD8A—leprosy	3.13e-05	0.000704	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—RIPK2—leprosy	3.12e-05	0.000702	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—TLR2—leprosy	3.12e-05	0.000702	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HLA-DRB1—leprosy	3.11e-05	0.0007	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	3.07e-05	0.000691	CbGpPWpGaD
Pazopanib—LYN—Immune System—TLR2—leprosy	3.06e-05	0.000688	CbGpPWpGaD
Pazopanib—LYN—Immune System—RIPK2—leprosy	3.06e-05	0.000688	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—RIPK2—leprosy	3.05e-05	0.000687	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	2.97e-05	0.000669	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—RIPK2—leprosy	2.91e-05	0.000655	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD40LG—leprosy	2.86e-05	0.000643	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NOD2—leprosy	2.83e-05	0.000637	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD8A—leprosy	2.83e-05	0.000635	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD40LG—leprosy	2.81e-05	0.000631	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—CD4—leprosy	2.79e-05	0.000627	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HLA-DRB1—leprosy	2.78e-05	0.000625	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD8A—leprosy	2.78e-05	0.000624	CbGpPWpGaD
Pazopanib—LYN—Immune System—NOD2—leprosy	2.77e-05	0.000623	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—CD4—leprosy	2.74e-05	0.000615	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—IL2—leprosy	2.69e-05	0.000606	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—TNF—leprosy	2.68e-05	0.000602	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD4—leprosy	2.68e-05	0.000602	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD40LG—leprosy	2.66e-05	0.000599	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD40LG—leprosy	2.66e-05	0.000597	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD8A—leprosy	2.63e-05	0.000592	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD4—leprosy	2.63e-05	0.000591	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD8A—leprosy	2.63e-05	0.000591	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—CD4—leprosy	2.6e-05	0.000584	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—CD4—leprosy	2.59e-05	0.000583	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	2.55e-05	0.000573	CbGpPWpGaD
Pazopanib—LCK—Immune System—RIPK2—leprosy	2.51e-05	0.000564	CbGpPWpGaD
Pazopanib—LCK—Immune System—TLR2—leprosy	2.51e-05	0.000564	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD4—leprosy	2.5e-05	0.000561	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD4—leprosy	2.49e-05	0.000559	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL2—leprosy	2.46e-05	0.000554	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IFNG—leprosy	2.44e-05	0.000549	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—RIPK2—leprosy	2.41e-05	0.000542	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD40LG—leprosy	2.39e-05	0.000538	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—RIPK2—leprosy	2.37e-05	0.000532	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD8A—leprosy	2.37e-05	0.000532	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD4—leprosy	2.36e-05	0.000531	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD40LG—leprosy	2.34e-05	0.000527	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—IL2—leprosy	2.34e-05	0.000525	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CD4—leprosy	2.33e-05	0.000525	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD8A—leprosy	2.32e-05	0.000521	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HLA-DRB1—leprosy	2.3e-05	0.000517	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CD4—leprosy	2.29e-05	0.000514	CbGpPWpGaD
Pazopanib—LCK—Immune System—NOD2—leprosy	2.27e-05	0.000511	CbGpPWpGaD
Pazopanib—KIT—Immune System—HLA-DRB1—leprosy	2.26e-05	0.000508	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RIPK2—leprosy	2.25e-05	0.000505	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RIPK2—leprosy	2.24e-05	0.000504	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD4—leprosy	2.24e-05	0.000504	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD4—leprosy	2.2e-05	0.000493	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CD4—leprosy	2.18e-05	0.00049	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL2—leprosy	2.17e-05	0.000488	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HLA-DRB1—leprosy	2.15e-05	0.000482	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HLA-DRB1—leprosy	2.14e-05	0.000481	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SDHD—leprosy	2.13e-05	0.000478	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IFNG—leprosy	2.03e-05	0.000457	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RIPK2—leprosy	2.02e-05	0.000454	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RIPK2—leprosy	1.98e-05	0.000445	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TNF—leprosy	1.97e-05	0.000443	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD4—leprosy	1.96e-05	0.000441	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HLA-DRB1—leprosy	1.93e-05	0.000433	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD40LG—leprosy	1.92e-05	0.000432	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IL2—leprosy	1.91e-05	0.00043	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD8A—leprosy	1.9e-05	0.000427	CbGpPWpGaD
Pazopanib—LYN—Immune System—HLA-DRB1—leprosy	1.89e-05	0.000424	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD4—leprosy	1.87e-05	0.000421	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SDHD—leprosy	1.85e-05	0.000417	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL2—leprosy	1.84e-05	0.000413	CbGpPWpGaD
Pazopanib—FGF1—Disease—CD4—leprosy	1.81e-05	0.000407	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL2—leprosy	1.81e-05	0.000406	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD4—leprosy	1.8e-05	0.000404	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SDHD—leprosy	1.75e-05	0.000393	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—leprosy	1.73e-05	0.00039	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IFNG—leprosy	1.68e-05	0.000378	CbGpPWpGaD
Pazopanib—KIT—Immune System—IFNG—leprosy	1.65e-05	0.000371	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD4—leprosy	1.62e-05	0.000365	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RIPK2—leprosy	1.62e-05	0.000364	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD4—leprosy	1.59e-05	0.000358	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.59e-05	0.000358	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IFNG—leprosy	1.57e-05	0.000352	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IFNG—leprosy	1.56e-05	0.000351	CbGpPWpGaD
Pazopanib—LCK—Immune System—HLA-DRB1—leprosy	1.55e-05	0.000348	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD4—leprosy	1.51e-05	0.00034	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—leprosy	1.51e-05	0.000339	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—leprosy	1.5e-05	0.000337	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2—leprosy	1.49e-05	0.000336	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SDHD—leprosy	1.48e-05	0.000333	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—leprosy	1.47e-05	0.000331	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2—leprosy	1.47e-05	0.00033	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—leprosy	1.41e-05	0.000317	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—leprosy	1.4e-05	0.000316	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—leprosy	1.4e-05	0.000314	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—leprosy	1.39e-05	0.000313	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—leprosy	1.39e-05	0.000313	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—leprosy	1.39e-05	0.000312	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—leprosy	1.38e-05	0.00031	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—leprosy	1.36e-05	0.000306	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—leprosy	1.33e-05	0.000299	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—leprosy	1.26e-05	0.000282	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—leprosy	1.26e-05	0.000282	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—leprosy	1.25e-05	0.000281	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—leprosy	1.23e-05	0.000275	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—leprosy	1.22e-05	0.000275	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—leprosy	1.17e-05	0.000262	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SDHD—leprosy	1.14e-05	0.000257	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—leprosy	1.13e-05	0.000254	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—leprosy	1.09e-05	0.000245	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—leprosy	1.01e-05	0.000226	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—leprosy	1e-05	0.000226	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—leprosy	9.66e-06	0.000217	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—leprosy	9.49e-06	0.000213	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—leprosy	9e-06	0.000202	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—leprosy	8.98e-06	0.000202	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—leprosy	8.09e-06	0.000182	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—leprosy	7.92e-06	0.000178	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—leprosy	6.49e-06	0.000146	CbGpPWpGaD
